Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (G077814N, G077814N, G0A4616N, G0A4616N)
Onderzoeksraad, KU Leuven (3M14022, 3M14022)
Hrvatska Zaklada za Znanost (IP-2016-06-6272)
Received: 7 March 2022
Accepted: 9 August 2022
First Online: 29 August 2022
: L.P., V.Z., S.V.S., A.V.A., and I.G.-S. declare no competing interests. S.D.W. is an employee of Pledge Therapeutics B.V. and therefore declares a potential competing interest.